A5109683090- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Parathyroid Disorders and Treatments
- Cardiac pacing and defibrillation studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cardiac Valve Diseases and Treatments
- Coronary Interventions and Diagnostics
- Sarcoidosis and Beryllium Toxicity Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Hematopoietic Stem Cell Transplantation
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Pulmonary Hypertension Research and Treatments
- Parasitic infections in humans and animals
- Pain Management and Treatment
- Regulation of Appetite and Obesity
- Polyomavirus and related diseases
- Urological Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Receptor Mechanisms and Signaling
- Advanced MRI Techniques and Applications
- Inflammatory Biomarkers in Disease Prognosis
City Of Hope National Medical Center
2019-2024
City of Hope
2019-2024
Centre Hospitalier Universitaire Hassan II
2010
Cedars-Sinai Medical Center
2005-2007
University of California, Los Angeles
2006
Lille’s Cardiology Hospital
1999
Society for Neuroscience
1999
There is a paucity of information on the association between clonal hematopoiesis indeterminate potential (CHIP) and cardiovascular disease (CVD) in patients with cancer, including those multiple myeloma (MM) undergoing hematopoietic cell transplant (HCT), population at high risk developing CVD after HCT.
Growing evidence suggests a wide spectrum of potential cardiovascular complications following cancer therapies, leading to an urgent need for better risk-stratifying and disease screening in patients undergoing oncological treatment. As many undergo frequent surveillance through imaging as well other diagnostic testing, there is wealth information that can be utilized assess one's risk therapies. Over the past decade, have been remarkable advances applying artificial intelligence (AI)...
Cells within the lateral hypothalamic area (LHA) are important in eating control. Glutamate or its analogs, kainic acid (KA) and N-methyl-D-aspartate (NMDA), elicit intense when microinjected there, and, conversely, LHA-administered NMDA receptor antagonists suppress deprivation- NMDA-elicited eating. The subunit composition of LHA receptors (NMDA-Rs) mediating feeding, however, has not yet been determined. Identifying this is important, because distinct second messengers/modulators may be...
Our aim was to define the anatomy of coronary sinus (CS) by venography. These measurements are essential in selection physical characteristics percutaneous annuloplasty devices for mitral regurgitation (MR).Clinical trials CS MR now underway. Although is close proximity annulus, there as yet no published quantitative data defining magnitude change dimensions MR, and how these changes might reflect MR.We studied 57 patients (27 with 30 MR) who were referred cardiac resynchronization therapy...
Patients undergoing autologous hematopoietic cell transplantation (HCT) have a >2-fold risk of developing cardiovascular disease (CVD; heart failure, myocardial infarction, and stroke), compared to the general population. Coronary artery calcium (CAC) is predictive CVD in nononcology patients but not as well studied who underwent HCT survivors HCT.The objective this study was examine association between CAC outcomes after with lymphoma.
Patients with lymphoma are at high risk for developing heart failure (HF) after autologous hematopoietic cell transplantation (HCT). More accurate determination pre-HCT may facilitate screening and prevention of HF. The aim this study was to examine the association between clonal hematopoiesis indeterminate potential (CHIP) HF HCT lymphoma. This a retrospective cohort 861 patients who underwent 2010 2016 City Hope Comprehensive Cancer Center. Targeted DNA sequencing performed determine...
Background: Hematopoietic cell transplantation (HCT) is an established curative treatment for patients with hematologic malignancies, however survivors are at a >4-fold risk of cardiovascular disease ([CVD] heart failure, myocardial infarction, stroke]) compared to the general population. Coronary artery calcium (CAC) predictive CVD in non-oncology patients; less known about its association and outcomes after HCT. Methods: This was retrospective cohort study 243 consecutive who underwent...